The number you gave ($11.24B) was a WW number. INNV isn't a world wide company at this time. They don't have the best marketing channels in Key EU countries. I would put their realistic market share at $20M by 2023.
Also, one must consider other competition coming in. Costco is a big threat to INNV sales. For instance they sell their equiv. Fluticasone Proprionate for approximately 30-40% less than Amazon does.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.